The more attractive advantage of miR-22 as a target for targeting WNT signaling is that it could effectively block WNT/β-catenin signaling in cSCC or even with APC or CTNNB1 mutations by promoting degradation of citrullinated β-catenin [27, 38, 39]. Here, APC is linked to skin squamous cell carcinoma.